Exciting News: Tiefenbacher Group Earns EcoVadis Silver Medal!
We are thrilled to announce that Tiefenbacher Group has been awarded the EcoVadis Silver Medal, highlighting our strong commitment to sustainability across the board.
This achievement is a testament to the hard work and dedication of our teams at Tiefenbacher Pharmaceuticals, Tiefenbacher Laboratories, and Delorbis Pharmaceuticals Ltd . The silver medal places us in the top 15% of companies assessed by EcoVadis globally, reflecting our advanced performance in key areas of sustainability:
-
Environment
-
Labor & Human Rights
-
Ethics
-
Sustainable Procurement
EcoVadis, the world’s largest provider of business sustainability ratings, evaluates how well companies integrate sustainability principles into their business and management systems. We are proud to have reached the 85th+ percentile, underscoring the maturity of our sustainability practices.
At TIEFENBACHER GROUP, we recognize that our responsibility as a global healthcare leader extends beyond medicine. We are committed to making a positive impact on society and our planet, and we will continue to push forward in our sustainability journey.
A huge thank you to our incredible colleagues for their ongoing contributions to this achievement! Together, we are making a difference.
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com
